Urolithin On A Mission

Mitochondrial Health is The New Craze

Table of Contents

For those who are new here, I publish research on optimization methods, supplements, and strategies each week. I am not a medical professional or an expert, rather I am a passionate consumer. Optimizer is designed to help lay people like you and me decode the medical journals, marketing speak, and influencer messaging.

Optimization Insight: Pom Wonderful

Urolithin A appears to be one of the most hyped compounds as of late. Even so, the compound is still relatively unknown by the mass market. In fact: as the leading retailer of the pomegranate-derived compound, the approach to Mitopure’s marketing could eventually be called into question in ways that another pomegranate-adjacent retail brand experienced. Most of the medical journal research has been authored by employees, corporate board members, or scientific board members according to conflict of interest reporting at the foots of the growing library of journal articles.

We have seen this before with Pom Wonderful’s use of scientific claims derived from work authored by those associated with the company. Here’s one example from 2013 and a conflict of interest statement that says:

Dr. Carducci was an unpaid consultant to Pom Wonderful during the conduct of this study, but that relationship is no longer active. Dr. Heber is a paid consultant to Pom Wonderful.

Founded in 2002, Pom Wonderful pioneered an approach to product marketing based on credibility by medical journal. A 2016 Forbes report shared the story of the FTC questioning of their style of advertising. The then-VP of Communications responded by pointing out that the commission only questioned “36 of 600 advertisements” but highlighted: "We continue to stand behind our efforts to publicly convey valuable information about the health benefits of POM, as well as the $40 million in peer-reviewed, scientific research we’ve conducted regarding the power of this amazing fresh fruit.”

Subscribe to keep reading

This content is free, but you must be subscribed to Optimizer to continue reading.

Already a subscriber?Sign In.Not now

Reply

or to participate.